BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32725236)

  • 1. Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction.
    Soble A; Patel Z; Sosler S; Hampton L; Johnson H
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S160-S164. PubMed ID: 32725236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK.
    Meiring JE; Gibani M;
    Vaccine; 2017 Sep; 35(38):5081-5088. PubMed ID: 28802757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
    Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
    Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries.
    Shakya M; Neuzil KM; Pollard AJ
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S770-S774. PubMed ID: 34374785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.
    Mogasale V; Ramani E; Park IY; Lee JS
    Hum Vaccin Immunother; 2017 Sep; 13(9):2017-2024. PubMed ID: 28604164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
    Steele AD; Carey ME; Kumar S; MacLennan CA; Ma LF; Diaz Z; Zaidi AKM
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S185-S190. PubMed ID: 32725223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised Global Typhoid Vaccination Policy.
    Bentsi-Enchill AD; Hombach J
    Clin Infect Dis; 2019 Feb; 68(Suppl 1):S31-S33. PubMed ID: 30767001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
    Carey ME; Diaz ZI; Broadstock M; Bailey R; Bentsi-Enchill AD; Larson HJ
    Clin Infect Dis; 2019 Oct; 69(Suppl 5):S408-S411. PubMed ID: 31612940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
    Debellut F; Mkisi R; Masoo V; Chisema M; Mwagomba D; Mtenje M; Limani F; Mategula D; Zimba B; Pecenka C
    Vaccine; 2022 Mar; 40(12):1741-1746. PubMed ID: 35153097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.
    Debellut F; Hendrix N; Pitzer VE; Neuzil KM; Constenla D; Bar-Zeev N; Marfin A; Pecenka C
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S154-S160. PubMed ID: 30845321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Neuzil KM; Pollard AJ; Marfin AA
    Clin Infect Dis; 2019 Feb; 68(Suppl 1):S27-S30. PubMed ID: 30767005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
    Jeon HJ; Im J; Haselbeck A; Holm M; Rakotozandrindrainy R; Bassiahi AS; Panzner U; Mogeni OD; Seo HJ; Lunguya O; Jacobs J; Okeke IN; Terferi M; Owusu-Dabo E; Dougan G; Carey M; Steele AD; Kim JH; Clemens JD; Andrews JR; Park SE; Baker S; Marks F
    Clin Infect Dis; 2019 Oct; 69(Suppl 6):S417-S421. PubMed ID: 31665772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas.
    Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of typhoid vaccine in the expanded immunization program of Pakistan.
    Aslam F; Yue Y; Aziz M
    Hum Vaccin Immunother; 2021 Jul; 17(7):2132. PubMed ID: 33522429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward.
    Russell AL; Hampton LM; Sinha A; Luquero FJ; Abdelwahab J
    Open Forum Infect Dis; 2023 May; 10(Suppl 1):S13-S16. PubMed ID: 37274531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study.
    Birger R; Antillón M; Bilcke J; Dolecek C; Dougan G; Pollard AJ; Neuzil KM; Frost I; Laxminarayan R; Pitzer VE
    Lancet Infect Dis; 2022 May; 22(5):679-691. PubMed ID: 35123673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Theiss-Nyland K; Shakya M; Colin-Jones R; Voysey M; Smith N; Karkey A; Dongol S; Pant D; Farooq YG; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S67-S73. PubMed ID: 30845329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Theiss-Nyland K; Qadri F; Colin-Jones R; Zaman K; Khanam F; Liu X; Voysey M; Khan A; Hasan N; Ashher F; Farooq YG; Pollard AJ; Clemens JD
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S74-S82. PubMed ID: 30845333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Insights From Clinical Trials of Typhoid Conjugate Vaccine.
    Neuzil KM; Basnyat B; Clemens JD; Gordon MA; Patel PD; Pollard AJ; Shakya M; Qadri F
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S155-S159. PubMed ID: 32725230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.